Corient Private Wealth’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
Corient Private Wealth's CBIO Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 19,610 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #2788 among its holdings.
104 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.
- Corient Private Wealth held 19,610 shares of Crescent Biopharma worth $286K as of Q3 2026.
- Crescent Biopharma was a new Corient Private Wealth position in Q3 2026.
- Crescent Biopharma made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2788 holding.
- 104 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.